Hannah Lu

539 total citations
9 papers, 441 citations indexed

About

Hannah Lu is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hannah Lu has authored 9 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hannah Lu's work include Analytical Methods in Pharmaceuticals (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). Hannah Lu is often cited by papers focused on Analytical Methods in Pharmaceuticals (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Innovative Microfluidic and Catalytic Techniques Innovation (1 paper). Hannah Lu collaborates with scholars based in United States and Russia. Hannah Lu's co-authors include Man‐Wai Lo, Michael R. Goldberg, Thorir D. Bjornsson, Christine Furtek, Jacqueline B. McCrea, Dominic P. Ip, Marvin A. Brooks, Eric W. Tsai, Scott A. Waldman and Robert A. Blum and has published in prestigious journals such as Hypertension, Journal of Chromatography A and Clinical Pharmacology & Therapeutics.

In The Last Decade

Hannah Lu

9 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannah Lu United States 8 204 107 88 75 62 9 441
Sjoerd P. van Marle Switzerland 8 134 0.7× 69 0.6× 87 1.0× 76 1.0× 108 1.7× 8 533
David Silberstein United States 7 179 0.9× 40 0.4× 134 1.5× 57 0.8× 107 1.7× 15 490
Tsu‐Han Lin United States 13 371 1.8× 121 1.1× 75 0.9× 130 1.7× 149 2.4× 20 751
Maria Sunzel Sweden 11 158 0.8× 89 0.8× 41 0.5× 26 0.3× 69 1.1× 17 425
David J. Kazierad United States 14 166 0.8× 192 1.8× 103 1.2× 72 1.0× 136 2.2× 27 560
AN Brown United Kingdom 11 252 1.2× 120 1.1× 77 0.9× 38 0.5× 136 2.2× 20 492
E von Möllendorff United States 9 168 0.8× 46 0.4× 88 1.0× 46 0.6× 59 1.0× 12 430
B. Jackson Australia 8 241 1.2× 71 0.7× 63 0.7× 34 0.5× 84 1.4× 10 367
Roeline Jochemsen France 9 122 0.6× 50 0.5× 93 1.1× 141 1.9× 99 1.6× 12 496
Yong Ha South Korea 13 101 0.5× 70 0.7× 62 0.7× 49 0.7× 92 1.5× 23 375

Countries citing papers authored by Hannah Lu

Since Specialization
Citations

This map shows the geographic impact of Hannah Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Lu more than expected).

Fields of papers citing papers by Hannah Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Lu. The network helps show where Hannah Lu may publish in the future.

Co-authorship network of co-authors of Hannah Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Lu. A scholar is included among the top collaborators of Hannah Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Lu. Hannah Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lu, Hannah, et al.. (2021). Incidence and Risk Factors for Acute Kidney Injury in Hospitalized Children Receiving Piperacillin-Tazobactam. The Journal of Pediatric Pharmacology and Therapeutics. 26(6). 597–602. 2 indexed citations
2.
Lu, Hannah & Jonathan E. Dowell. (2019). Osimertinib in Pulmonary Manifestations: Two Case Reports and Review of the Literature. In Vivo. 34(1). 315–319. 9 indexed citations
3.
Murtaza, Ghulam, et al.. (2017). Multiple Myeloma-Induced Hyperammonemic Encephalopathy. Journal of Hematology. 6(1). 29–31. 7 indexed citations
4.
Murtaza, Ghulam, et al.. (2017). Acute Pancreatitis Related to a Chemotherapy Drug. World Journal of Oncology. 8(1). 18–19. 7 indexed citations
5.
Murtaza, Ghulam, et al.. (2017). An Interesting Case of Tolosa-Hunt Syndrome in a Young Male. Journal of Investigative Medicine High Impact Case Reports. 5(1). 2733154630–2733154630. 9 indexed citations
6.
Lo, Man‐Wai, Scott E. Emmert, Michael Ritter, et al.. (1998). Pharmacokinetics of Intravenous and Oral Losartan in Patients with Heart Failure. The Journal of Clinical Pharmacology. 38(6). 525–532. 18 indexed citations
7.
Lo, Man‐Wai, Michael R. Goldberg, Jacqueline B. McCrea, et al.. (1995). Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clinical Pharmacology & Therapeutics. 58(6). 641–649. 231 indexed citations
8.
Goldberg, Michael R., Thomas E. Bradstreet, Wesley Tanaka, et al.. (1995). Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients. Hypertension. 25(1). 37–46. 110 indexed citations
9.
Tsai, Eric W., et al.. (1992). Application of capillary electrophoresis to pharmaceutical analysis. Journal of Chromatography A. 626(2). 245–250. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026